ERBB2 and neoplasm: Since the HER2-CD3-Fc bsAb induces strong T-cell-dependent killing of HER2-positive tumor cells, we tested whether T cells would kill tumor cells transfected directly with the HER2-CD3-Fc mRNA-LNPs.